Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lehmann

Showing results (361-370 of 410) with videos related to

Pageof 41
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1996
Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivoP Hafkemeyer, A Keppler-Hafkemeyer, M A al Haya, et al.
Plos One|June 24, 2011
Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II moleculesGerd Meyer zu Hörste, Anne K Mausberg, Johanna I Müller, et al.
Journal of Neurology|September 30, 2022
MRI correlates of motoneuron loss in SMAAlina Sprenger-Svačina, Johannes Haensch, Kilian Weiss, et al.
European Journal of Medical Research|August 5, 2011
Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohortB Steffens, T Kümmerle, S Koch, et al.
European Journal of Neurology|January 18, 2023
The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathyMartin K R Svačina, Alina Sprenger-Svačina, Anastasia Tsakmaklis, et al.
Infection|April 26, 2012
Liver involvement in HIV-infected patients diagnosed with syphilisN Jung, T Kümmerle, S D Brengelmann, et al.
European Journal of Neurology|October 4, 2023
Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational studyMartin K R Svačina, Anika Meißner, Finja Schweitzer, et al.
Annals of Clinical and Translational Neurology|July 29, 2022
Amyloidogenicity assessment of transthyretin gene variantsNicolai B Grether, Felix Napravnik, Thomas Imhof, et al.
BMJ Open|April 27, 2019
Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISHFiona Streckmann, Viviane Hess, Wilhelm Bloch, et al.
JAMA Internal Medicine|July 1, 2024
Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy: A Randomized Clinical TrialFiona Streckmann, Thomas Elter, Helmar C Lehmann, et al.
Pageof 41

Showing results (361-370 of 410) with videos related to

Sort By:
Pageof 41
Antimicrobial Agents and Chemotherapy|March 1, 1996
Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivoP Hafkemeyer, A Keppler-Hafkemeyer, M A al Haya, et al.
Plos One|June 24, 2011
Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II moleculesGerd Meyer zu Hörste, Anne K Mausberg, Johanna I Müller, et al.
Journal of Neurology|September 30, 2022
MRI correlates of motoneuron loss in SMAAlina Sprenger-Svačina, Johannes Haensch, Kilian Weiss, et al.
European Journal of Medical Research|August 5, 2011
Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the Cologne-Bonn cohortB Steffens, T Kümmerle, S Koch, et al.
European Journal of Neurology|January 18, 2023
The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathyMartin K R Svačina, Alina Sprenger-Svačina, Anastasia Tsakmaklis, et al.
Infection|April 26, 2012
Liver involvement in HIV-infected patients diagnosed with syphilisN Jung, T Kümmerle, S D Brengelmann, et al.
European Journal of Neurology|October 4, 2023
Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational studyMartin K R Svačina, Anika Meißner, Finja Schweitzer, et al.
Annals of Clinical and Translational Neurology|July 29, 2022
Amyloidogenicity assessment of transthyretin gene variantsNicolai B Grether, Felix Napravnik, Thomas Imhof, et al.
BMJ Open|April 27, 2019
Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial-VANISHFiona Streckmann, Viviane Hess, Wilhelm Bloch, et al.
JAMA Internal Medicine|July 1, 2024
Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy: A Randomized Clinical TrialFiona Streckmann, Thomas Elter, Helmar C Lehmann, et al.
Pageof 41